Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
So-Young Intl (NASDAQ: SY ) held its second-quarter earnings conference call on Monday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary So-Young Intl reported Q2 2026 revenue of RMB 510 million, a 33% y
Reuters (Sept 16) provided consolidated earnings estimates for TOC Co Ltd, showing a higher annual dividend forecast of 11.00 yen versus the latest previous forecast of 10.00 yen. It also shows Q2 dividend at 5.50 yen versus 5.00 yen and a higher Q4 dividend versus the prior forecast (figures truncated in the provided
U.S. annual inflation was unchanged at 3.4% in August, matching expectations, while core inflation eased to 2.4% year over year. The monthly CPI rose 0.4%, with gasoline the biggest driver.
The EIA now expects Brent crude to average about $91 a barrel in 2026 and WTI $84.65, both higher than its prior forecast. The agency said global oil stocks have fallen by an estimated 400 million barrels this year and cited reduced Middle East production and exports.
Iran Reignites Strait Of Hormuz Fight As US Tightens Squeeze Houthis Take Control Of Red Sea Port City Mocha Trump s Advisers Confront Possibility Iran War Lasts Through Term UK Home Prices Remain Under Pressure As Mortgage Costs Rise BoJ s Masu: Will Continue To Raise Benchmark Rate China Willing To Hold AI Talks With
ABM said it posted record quarterly revenue in Q3 2026, delivered 27% adjusted EPS growth and raised its full-year free cash flow outlook after stronger year-to-date cash generation.
The latest picks from Wall Street's most accurate analysts included buy and neutral calls, with target increases for Broadcom and DocuSign and cuts for Ambarella and Intel. Xtend AI Robotics was also initiated at Buy.
U.S. equities slipped as August payrolls of 162,000, far above the 55,000 consensus, pushed traders toward a higher Fed-rate path. Chips outperformed while software, retail, gold and bitcoin weakened.
DocuSign reported Q2 revenue of $876 million, up 9% year over year, with a 32% operating margin and about $300 million in free cash flow. It also raised fiscal 2027 ARR guidance and said IAM now accounts for 15.1% of total ARR.
Friday's August employment report may decide whether the Fed pauses or raises rates on Sept. 16, with CME FedWatch pricing a 50-50 split. Economists expect 56,000 jobs added, unemployment at 4.1% and hourly earnings up 0.3% month on month.
Salesforce shares rose 3.98% to $267.14 Thursday, extending a post-earnings rally after fiscal second-quarter 2027 revenue and adjusted profit beat estimates and the company announced an Anthropic partnership.
Snowflake reported Q2 EPS of $0.62 versus $0.45 expected and revenue of $1.55 billion versus $1.48 billion expected, while raising FY27 product revenue guidance to $6.07 billion from $5.84 billion.
Marvell Technology shares were down 1.33% at $203.74 in premarket trading Thursday as investors rotated away from elevated valuation technology stocks.
U.S. equities advanced Wednesday, with the S&P 500 up 0.5% and the Dow up 0.4%, as AI dealmaking helped offset declines in software and cybersecurity shares.
BoJ policymaker Kazuo Ueda said rates would keep rising as inflation risks grow. RBNZ raised the OCR to 2.75% by 25 bps, while global bonds sold off on inflation fears.
Exxon Mobil shares are trading higher by almost 2% Monday as traders react to Venezuela investment headlines, with S&P 500 futures down 0.4%.
Chevron shares rose more than 2% in Monday premarket trading as traders reacted to headlines about a potential major U.S. investment push in Venezuela's oil sector.
Marvell Technology fell nearly 8% premarket after its Q2 results and raised outlook, as investors focused on valuation concerns. The company posted revenue of $2.74 billion and adjusted EPS of 94 cents, and lifted next-quarter guidance.
The White House is weighing a new round of tariffs on chips, according to LiveSquawk’s US briefing.
Salesforce reported fiscal second-quarter revenue of $11.35 billion and adjusted earnings of $5.90 a share, both above consensus. It also lifted fiscal 2027 revenue and full-year adjusted earnings guidance and announced an Anthropic partnership.
Zoom said total revenue was $1.28 billion in fiscal second-quarter earnings and raised full-year guidance to $5.085 billion to $5.095 billion, while enterprise revenue rose 7.8% to $787.5 million.
U.S. futures were mixed Wednesday, with Dow Jones futures higher and S&P 500 and Nasdaq 100 futures slightly lower, as investors awaited Nvidia's second-quarter earnings and key inflation and GDP data.
Ross Stores reported second-quarter revenue of $6.27 billion and earnings of $2.66 per share, both above estimates, and lifted 2026 earnings guidance to $8.61-$8.77 per share.
Arlo Technologies says it was “actually profitable,” reported second-quarter EPS of 28 cents versus the 20-cent estimate, and revenue of $155.937 million versus $148.750 million, while also issuing strong third-quarter sales guidance and FY26 guidance above estimates.
Bank of America raised price targets on 10 software stocks, saying fears of AI disruption are easing while it favors names with stronger growth and emerging AI monetization.
Keysight Technologies reported adjusted Q3 EPS of $3.07 on revenue of $1.846 billion, both above estimates, and raised fourth-quarter and fiscal 2026 guidance.
Simon Property Group said quarterly revenue beat analyst estimates, EPS missed, and it raised full-year FFO guidance after reporting U.S. mall occupancy at 96%.
Bank of America raises Target's earnings estimates and price forecast to $124
Yardeni Research raises S&P 500 year-end target to 8,400
Natera Inc. (NASDAQ: NTRA ) stock surged Friday after the genetic testing company reported second-quarter results that topped Wall Street estimates and raised its full-year revenue outlook, supported by strong oncology demand and continued momentum across its Women’s Health and Organ Health businesses. The company repo